JUPITER NEUROSCIENCES, INC. (JUNS) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001679628 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 14, 2026 | $24,245 | $-2.3M | $-4.08 | Filing |
| Mar 31, 2026 | May 14, 2026 | $18,652 | $-2.1M | $-0.06 | Filing |
| Dec 31, 2025 | Apr 1, 2026 | — | $-2.6M | $4.96 | Filing |
| Sep 30, 2025 | Nov 14, 2025 | — | $-2.3M | $-0.07 | Filing |
| Jun 30, 2025 | Aug 19, 2025 | — | $-2.3M | $-5.09 | Filing |
| Mar 31, 2025 | May 15, 2025 | $0 | $-1.5M | $-0.05 | Filing |
| Dec 31, 2024 | Mar 28, 2025 | — | $-1.5M | $-0.05 | Filing |
| Sep 30, 2024 | Dec 23, 2024 | — | $-591,021 | $-0.02 | Filing |
What would JUPITER NEUROSCIENCES, INC. have to report for its valuation to change?
At $2.90, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -19.8% a year, to $0.25. On that path the next quarter needs diluted EPS near $-0.06, against $-0.07 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -19.8% | -19.8% |
| EPS needed in final year | $0.25 | $0.25 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. JUNS goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.